DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Mattioli M, Benfaremo D, Mancini M. et al.
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.
J Thromb Thrombolysis 2020;
DOI: 10.1007/s11239-020-02243-z.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.